SKI Market

A+| A| A-|

Indian Indices

Sensex

73,832.55 -150.63
( -0.20%)

Global Indices

Nasdaq

49,934.70 -958.41
(-1.88%)

Dow Jones

7,287.94 -119.71
(-1.62%)

Hang Seng

64,050.08 -129.19
(-0.20%)

Nikkei 225

10,316.43 61.62
(0.60%)

Forex

USD-INR

95.41 -0.12
(-0.12%)

EUR-INR

110.18 0.04
(0.03%)

GBP-INR

127.60 0.17
(0.13%)

JPY-INR

0.60 0.00
(-0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jubilant Pharmova Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

530019

INE700A01033

145.1556811

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

JUBLPHARMA

489.52

15362.1

EPS(TTM)

Face Value()

Div & Yield %

1.97

0.52

Back

Rose Merc. consolidated net profit rises 72.34% in the December 2025 quarter

Feb 13,2026

Net profit of Rose Merc. rose 72.34% to Rs 0.81 crore in the quarter ended December 2025 as against Rs 0.47 crore during the previous quarter ended December 2024. Sales rose 620.13% to Rs 21.46 crore in the quarter ended December 2025 as against Rs 2.98 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	21.46	2.98	620
OPM %	13.84	15.10	-
PBDT	2.97	0.47	532
PBT	2.92	0.45	549
NP	0.81	0.47	72

73,832.55 -150.63 ( -0.20%)

49,934.70 -958.41 (-1.88%)

7,287.94 -119.71 (-1.62%)

64,050.08 -129.19 (-0.20%)

10,316.43 61.62 (0.60%)

95.41 -0.12 (-0.12%)

110.18 0.04 (0.03%)

127.60 0.17 (0.13%)

0.60 0.00 (-0.17%)